<HashMap><database>biostudies-other</database><scores/><additional><omics_type>Unknown</omics_type><volume>66(Pt 2)</volume><submitter>Chen P</submitter><journal>Acta crystallographica. Section E, Structure reports online</journal><pagination>o274</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC2979877</full_dataset_link><abstract>The title compound, C(10)H(7)FO(4), is an inter-mediate in the synthesis of the drug Fidarestat, (2S,4S)-2-aminoformyl-6-fluoro-spiro[chroman-4,4'-imidazolidine]-2',5'-dione. The di-hydro-pyran-one ring adopts an envelope conformation with the asymmetric C atom in the flap position. In the crystal, the mol-ecules are linked into zigzag chains along [100] by O-H?O hydrogen bonds and C-H?? inter-actions involving the benzene ring.</abstract><repository>biostudies-other</repository><pmcid>PMC2979877</pmcid><data_source>Europe PMC</data_source><pubmed_authors>Chen P</pubmed_authors><pubmed_authors>Qian S</pubmed_authors><pubmed_authors>Wu Y</pubmed_authors><pubmed_authors>Shi ZQ</pubmed_authors></additional><is_claimable>false</is_claimable><name>6-Fluoro-4-oxochroman-2-carboxylic acid.</name><description>The title compound, C(10)H(7)FO(4), is an inter-mediate in the synthesis of the drug Fidarestat, (2S,4S)-2-aminoformyl-6-fluoro-spiro[chroman-4,4'-imidazolidine]-2',5'-dione. The di-hydro-pyran-one ring adopts an envelope conformation with the asymmetric C atom in the flap position. In the crystal, the mol-ecules are linked into zigzag chains along [100] by O-H?O hydrogen bonds and C-H?? inter-actions involving the benzene ring.</description><dates><release>2010-01-01T00:00:00Z</release><publication>2010 </publication><modification>2019-03-27T00:00:56Z</modification><creation>2019-03-27T00:00:56Z</creation></dates><accession>S-EPMC2979877</accession><cross_references><pubmed>21579711</pubmed><doi>10.1107/S1600536809054555 </doi></cross_references></HashMap>